IGN-501

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIGN-501
Drug Alias Nameimmunoregulatory vaccine (Igeneon)autoimmune disease/cancer vaccine (Igeneon)IGN-501
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesSkin DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIgeneon Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltropusIgeneon Ag
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesSkin DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A